Odontogenic myxoma is a rare benign neoplasm with locally aggressive behaviour and a high risk of recurrence. It has a predilection for the mandible and occurs in the 2nd–3rd decade. The authors report a case of an odontogenic myxoma presenting with a spontaneous oro‐nasal fistula in a 29‐year‐old male. Histo‐pathological analysis of the incisional biopsy specimen initially suggested a diagnosis of calcifying epithelial odontogenic tumour. A partial maxillectomy was performed, and following assessment of the resection specimen, a diagnosis of odontogenic myxoma was rendered. A 3 cm bicortical iliac crest bone graft was harvested and inset to the right maxillary defect under general anaesthesia. Rehabilitation will be completed with the placement of implants.
Elongation of the styloid process occurs in 4–7% of individuals. In the majority this elongation is asymptomatic. Presence of oropharyngeal pain and dysphagia with such elongation is known as Eagle syndrome. The aetiology of Eagle syndrome is believed to be a reactive osseus hyperplasia of the styloid process in response to pharyngeal trauma or surgical intervention, such as tonsillectomy. We present a case of a 72-year-old lady with a twelve month history of left sided oropharyngeal pain and worsening dysphagia, presenting with a long, slender, bony intraoral projection found to be an elongated styloid process. She previously underwent tonsillectomy and radiotherapy on the left side for a tonsillar carcinoma. Surgical reduction of the elongated styloid process via intraoral approach led to immediate post-operative pain relief and normal swallowing. We conclude that this atypical presentation of Eagle syndrome was caused by the patient's prior treatment for tonsillar carcinoma.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.